A Randomized Phase II Study of a Combination of Docetaxel and S-1 versus Docetaxel Monotherapy in Patients with Non-small Cell Lung Cancer Previously Treated with Platinum-Based Chemotherapy: Results of Okayama Lung Cancer Study Group (OLCSG) Trial 0503-Reference-Cited by-同舟云学术

A Randomized Phase II Study of a Combination of Docetaxel and S-1 versus Docetaxel Monotherapy in Patients with Non-small Cell Lung Cancer Previously Treated with Platinum-Based Chemotherapy: Results of Okayama Lung Cancer Study Group (OLCSG) Trial 0503

Published:2010-09 Issue:9 Volume:5 Page:1430-1434
ISSN:1556-0864
Container-title:Journal of Thoracic Oncology
language:en
Short-container-title:Journal of Thoracic Oncology

Author:

Segawa Yoshihiko,Kiura Katsuyuki,Hotta Katsuyuki,Takigawa Nagio,Tabata Masahiro,Matsuo Keitaro,Yoshioka Hiroshige,Hayashi Hidetoshi,Kawai Haruyuki,Aoe Keisuke,Maeda Tadashi,Ueoka Hiroshi,Tanimoto Mitsune

Publisher

Elsevier BV

Subject

Pulmonary and Respiratory Medicine,Oncology

Reference24 articles.

1. American Society of Clinical Oncology treatment of unresectable non-small-cell lung cancer guideline: update 2003;Pfister;J Clin Oncol,2004

2. Meta-analysis of randomized clinical trials comparing cisplatin to carboplatin in patients with advanced non-small-cell lung cancer;Hotta;J Clin Oncol,2004

3. Long-standing debate on cisplatin- versus carboplatin-based chemotherapy in the treatment of advanced non-small-cell lung cancer;Hotta;J Thorac Oncol,2007

4. Prospective randomized trial of docetaxel versus best supportive care in patients with non-small-cell lung cancer previously treated with platinum-based chemotherapy;Shepherd;J Clin Oncol,2000

5. Erlotinib in previously treated non-small-cell lung cancer;Shepherd;N Engl J Med,2005

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Continuation of immunotherapy beyond progression is beneficial to the survival of advanced non-small-cell lung cancer;Clinical and Translational Oncology;2023-12-25

2. A randomized phase III study of docetaxel alone versus docetaxel plus S‐1 in patients with previously treated non‐small cell lung cancer: JMTO LC09‐01;Thoracic Cancer;2023-08-23

3. Could S-1-based non-platinum doublet chemotherapy be a new option as a second-line treatment for advanced non-small cell lung cancer patients? A multicenter retrospective study;Frontiers in Oncology;2023-03-16

4. Disease control and objective responsive rates in randomized phase II trials evaluating non-first-line chemotherapy for non-small cell lung cancer: a systematic review of 74 trials;Translational Lung Cancer Research;2021-05

5. Phase I/II Study of Docetaxel and S-1 in Previously-Treated Patients with Advanced Non-Small Cell Lung Cancer: LOGIK0408;Journal of Clinical Medicine;2019-12-12